Atopic dermatitis (AD) in cats is a chronic inflammatory skin disease with an immunological basis. Its symptoms are often confused with food or parasitic allergies, which makes diagnosis difficult. The condition leads to itching, chronic skin inflammation and secondary infections.
To date, anti-inflammatory drugs (corticosteroids, cyclosporine), elimination diets and topical preparations have been used. These therapies alleviate symptoms, but do not always produce lasting effects, and long-term treatment with steroids is associated with the risk of adverse effects.
MSCs modulate the immune system and reduce abnormal inflammatory responses in the skin. When administered subcutaneously, they reduce itching, improve skin condition and reduce relapses. This is one of the most promising methods of treating chronic AD in cats.
👉 Check out how mesenchymal stem cells work
PRP supports skin regeneration, improves microcirculation and reduces inflammation. It can be used as a supportive therapy, especially in cats with chronic dermatological conditions.
👉 Learn more about PRP
In severe cases of AD, where inflammatory processes predominate, IL-1 therapy helps to reduce the severity of symptoms and improves the patient's quality of life.
👉 See more about IL-1 pain therapy and treatment
Atopic dermatitis in cats is a disease that requires a comprehensive approach. Standard treatment controls the symptoms, but only biological therapies – MSC, PRP and IL-1 – can significantly reduce the severity of the disease, limit relapses and improve the cat's quality of life.
AD is a chronic condition, but it can be effectively managed with biologic therapies.
Yes – autologous MSCs collected from the patient are used, which minimises the risk of complications.
Yes – it supports regeneration and reduces inflammation, especially in chronic lesions.
In severe, recurrent inflammatory conditions that do not respond to other treatments.
